UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 34

Sortiert nach

Penetrance Analysis of the PALB2 c.1592delT Founder Mutation

Clinical cancer research, 2008-07, Vol.14 (14), p.4667-4671

2008

Link zum Volltext

Verfügbarkeit prüfen

A CHEK2 Genetic Variant Contributing to a Substantial Fraction of Familial Breast Cancer

American journal of human genetics, 2002-08, Vol.71 (2), p.432-438

2002

Link zum Volltext

Verfügbarkeit prüfen

Population-Based Study of BRCA1 and BRCA2 Mutations in 1035 Unselected Finnish Breast Cancer Patients

JNCI : Journal of the National Cancer Institute, 2000-09, Vol.92 (18), p.1529-1531

2000

Link zum Volltext

Verfügbarkeit prüfen

Large genomic BRCA2 rearrangements and male breast cancer

Cancer detection and prevention, 2006-01, Vol.30 (6), p.530-534

2006

Link zum Volltext

Verfügbarkeit prüfen

Frequent amplification and overexpression of CCND1 in male breast cancer

International journal of cancer, 2004-10, Vol.111 (6), p.968-971

2004

Link zum Volltext

Verfügbarkeit prüfen

Mutations in the BRCA2 interacting DSS1 are not a risk factor for male breast cancer

International journal of cancer, 2007-01, Vol.120 (2), p.444-446

2007

Link zum Volltext

Verfügbarkeit prüfen

Hemochromatosis gene mutations among Finnish male breast and prostate cancer patients

International journal of cancer, 2006-01, Vol.118 (2), p.518-520

2006

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of the role of Finnish ataxia-telangiectasia mutations in hereditary predisposition to breast cancer

Carcinogenesis (New York), 2007-05, Vol.28 (5), p.1040-1045

2007

Link zum Volltext

Verfügbarkeit prüfen

Two percent of Finnish prostate cancer patients have a germ-line mutation in the hormone-binding domain of the androgen receptor gene

Cancer research (Chicago, Ill.), 2000-11, Vol.60 (22), p.6479-6481

2000

Link zum Volltext

Verfügbarkeit prüfen

BRCA2 Mutations in 154 Finnish Male Breast Cancer Patients

Neoplasia (New York, N.Y.), 2004-09, Vol.6 (5), p.541-545

2004

Link zum Volltext

Verfügbarkeit prüfen

NAD(P)H:quinone oxidoreductase 1 NQO12 genotype (P187S) is a strong prognostic and predictive factor in breast cancer

Nature genetics, 2008-07, Vol.40 (7), p.844-853

2008

Link zum Volltext

Verfügbarkeit prüfen

A recurrent mutation in PALB2 in Finnish cancer families

Nature, 2007-03, Vol.446 (7133), p.316-319

2007

Link zum Volltext

Verfügbarkeit prüfen

Androgen receptor gene alterations in finnish male breast cancer

Breast cancer research and treatment, 2003, Vol.77 (2), p.167-170

2003

Link zum Volltext

Verfügbarkeit prüfen

Analysis of p53 tumor suppressor gene in families with multiple glioma patients

Journal of neuro-oncology, 2001-12, Vol.55 (3), p.159-165

2001

Link zum Volltext

Verfügbarkeit prüfen

CHEK2 variant I157T may be associated with increased breast cancer risk

International journal of cancer, 2004-09, Vol.111 (4), p.543-547

2004

Link zum Volltext

Verfügbarkeit prüfen

Haplotype analysis in Icelandic and Finnish BRCA2 999del5 breast cancer families

European journal of human genetics : EJHG, 2001-10, Vol.9 (10), p.773-779

2001

Link zum Volltext

Verfügbarkeit prüfen

Correlation of CHEK2 protein expression and c.1100delC mutation status with tumor characteristics among unselected breast cancer patients

International journal of cancer, 2005-02, Vol.113 (4), p.575-580

2005

Link zum Volltext

Verfügbarkeit prüfen

Immunohistochemical Expression of DNA Repair Proteins in Familial Breast Cancer Differentiate BRCA2-Associated Tumors

Journal of clinical oncology, 2005-10, Vol.23 (30), p.7503-7511

2005

Link zum Volltext

Verfügbarkeit prüfen

Response: Re: Population-Based Study of BRCA1 and BRCA2 Mutations in 1035 Unselected Finnish Breast Cancer Patients

JNCI : Journal of the National Cancer Institute, 2001-01, Vol.93 (2), p.153-154

2001

Link zum Volltext

Verfügbarkeit prüfen

CHEK2 1100delC is not a risk factor for male breast cancer population

International journal of cancer, 2004-01, Vol.108 (3), p.475-476

2004

Link zum Volltext

Verfügbarkeit prüfen

BARD1 variants Cys557Ser and Val507Met in breast cancer predisposition

European journal of human genetics : EJHG, 2006-02, Vol.14 (2), p.167-172

2006

Link zum Volltext

Verfügbarkeit prüfen

ARLTS1 germline variants and the risk for breast, prostate, and colorectal cancer

European journal of human genetics : EJHG, 2008-08, Vol.16 (8), p.983-991

2008

Link zum Volltext

Verfügbarkeit prüfen

Matrix metalloproteinase 3 and 9 gene promoter polymorphisms: joint action of two loci as a risk factor for coronary artery complicated plaques

Atherosclerosis, 2005-05, Vol.180 (1), p.73-78

2005

Link zum Volltext

Verfügbarkeit prüfen

Low Proportion of BRCA1 and BRCA2 Mutations in Finnish Breast Cancer Families: Evidence for Additional Susceptibility Genes

Human molecular genetics, 1997-12, Vol.6 (13), p.2309-2315

1997

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 34

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(34)

Publikationsform

Artikel
(34)

Sprache

Englisch
(34)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Penetrance Analysis of the PALB2 c.1592delT Founder Mutation

A CHEK2 Genetic Variant Contributing to a Substantial Fraction of Familial Breast Cancer

Population-Based Study of BRCA1 and BRCA2 Mutations in 1035 Unselected Finnish Breast Cancer Patients

Large genomic BRCA2 rearrangements and male breast cancer

Frequent amplification and overexpression of CCND1 in male breast cancer

Mutations in the BRCA2 interacting DSS1 are not a risk factor for male breast cancer

Hemochromatosis gene mutations among Finnish male breast and prostate cancer patients

Evaluation of the role of Finnish ataxia-telangiectasia mutations in hereditary predisposition to breast cancer

Two percent of Finnish prostate cancer patients have a germ-line mutation in the hormone-binding domain of the androgen receptor gene

BRCA2 Mutations in 154 Finnish Male Breast Cancer Patients

NAD(P)H:quinone oxidoreductase 1 NQO12 genotype (P187S) is a strong prognostic and predictive factor in breast cancer

A recurrent mutation in PALB2 in Finnish cancer families

Androgen receptor gene alterations in finnish male breast cancer

Analysis of p53 tumor suppressor gene in families with multiple glioma patients

CHEK2 variant I157T may be associated with increased breast cancer risk

Haplotype analysis in Icelandic and Finnish BRCA2 999del5 breast cancer families

Correlation of CHEK2 protein expression and c.1100delC mutation status with tumor characteristics among unselected breast cancer patients

Immunohistochemical Expression of DNA Repair Proteins in Familial Breast Cancer Differentiate BRCA2-Associated Tumors

Response: Re: Population-Based Study of BRCA1 and BRCA2 Mutations in 1035 Unselected Finnish Breast Cancer Patients

CHEK2 1100delC is not a risk factor for male breast cancer population

A genomic map of a 6-Mb region at 13q21-q22 implicated in cancer development: identification and characterization of candidate genes

BARD1 variants Cys557Ser and Val507Met in breast cancer predisposition

ARLTS1 germline variants and the risk for breast, prostate, and colorectal cancer

Matrix metalloproteinase 3 and 9 gene promoter polymorphisms: joint action of two loci as a risk factor for coronary artery complicated plaques

Low Proportion of BRCA1 and BRCA2 Mutations in Finnish Breast Cancer Families: Evidence for Additional Susceptibility Genes

Suchergebnisse filtern